"Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent ..."

Giorgio Amendola et al. (2021)

> Home

Details and statistics

DOI: 10.1021/ACS.JCIM.1C00184

access: closed

type: Journal Article

metadata version: 2023-09-30

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/jcisd/AmendolaEPCMMHZ21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jcisd/AmendolaEPCMMHZ21
Giorgio Amendola, Roberta Ettari, Santo Previti, Carla Di Chio, Anna Messere, Salvatore Di Maro, Stefan J. Hammerschmidt, Collin Zimmer, Robert A. Zimmermann, Tanja Schirmeister, Maria Zappalà, Sandro Cosconati:
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening. J. Chem. Inf. Model. 61(4): 2062-2073 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.